Skip to content

Effect of on premature ejaculation

The effect of caffeine in comparison to conventional squeeze technique on controlling men with premature ejaculation, a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013091614677N1
Enrollment
78
Registered
2013-10-24
Start date
2013-10-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ejaculation. The inability to control ejaculation sufficiently for both partners to enjoy sexual interaction.

Interventions

Intervention 1: Group 3: intervention with placebo in this group identical tablets to Caffeine (without any effective content) are used. Intervention 2: Group 1: 50mg caffeine was administered on dema
Placebo
Treatment - Drugs
Treatment - Other
Group 3: intervention with placebo in this group identical tablets to Caffeine (without any effective content) are used.
Group 1: 50mg caffeine was administered on demand on every sexual contact with a single partner (married men with their wives) 2 hours before intercourse for 2 weeks and their ILET was assessed after
Group 2: using conventional squeezing technique. which is taught to each patient individually and the IELT is measured after 2 weeks of practice.

Sponsors

Behavioral Sciences resaerch Cener
Lead Sponsor
Vice chancellor for research (BMSU)
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA: All marries men (at least 6 months) patients with active sexual intercourse with diagnosed premature ejaculation based on (ICD-10) and functional premature ejaculation (IELT less than 60 seconds) associated with low desire and sexual partner complaint. Patients with other known organic or psychological disorder or patients with drugs or alcohol abuse were not included. EXCLUSION CRITERIA: 1-Any other new sexual dysfunction 2- Any other new clinical diagnosis 3- Any other new psychological disorder 4- Use of any drugs rather than Caffeine for PE during the study 5- Use of any antidepressant and psychotropic drug during the study 6- hyper sensitivity to caffeine in any phase of the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intravaginal Ejaculation Latency Time. Timepoint: every ejaculation for 2 weeks. Method of measurement: Chronometer by Sex Partner.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Hassan Saadat

Baqiatallah Medical Sciences University

saadat350@gmail.com+98 21 8248 3250

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 5, 2026